Oral Administration of Resveratrol-Selenium-Peptide Nanocomposites Alleviates Alzheimer’s Disease-like Pathogenesis by Inhibiting Aβ Aggregation and Regulating Gut Microbiota

• DOI: 10.1021/acsami.1c14818
• Publication Date: 2021-09-27T20:17:19Z
• Authors: Changjiang Li; Na Wang; Guodong Zheng; Licong Yang
• Keywords: Pathogenesis

Alzheimer's disease (AD) is a neurodegenerative associated with amyloid-β (Aβ) deposition, leading to neurotoxicity (oxidative stress and neuroinflammation) gut microbiota imbalance. Resveratrol (Res) has neuroprotective properties, but its bioavailability